1. Home
  2. SVA
  3. SVA News

Latest SINOVAC BIOTECH LTD (SVA) News on July 26, 2024

SVA

Business Wire

3 months ago

SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F

Here's Why Arch Capital Group (ACGL) is a Strong Momentum Stock
SVA

Zacks

6 months ago

Here's Why Arch Capital Group (ACGL) is a Strong Momentum Stock

Edgio Names BDO as Independent Auditor
SVA

Business Wire

6 months ago

Edgio Names BDO as Independent Auditor

The Housing Hiccup: 3 Stocks to Sell as the Real Estate Market Cools
SVA

InvestorPlace

6 months ago

The Housing Hiccup: 3 Stocks to Sell as the Real Estate Market Cools

Camber Energy Announces Agreement with Distributor for VKIN-Ozone Proprietary Waste Treatment System
SVA

ACCESSWIRE

6 months ago

Camber Energy Announces Agreement with Distributor for VKIN-Ozone Proprietary Waste Treatment System

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
SVA

GlobeNewswire

6 months ago

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024
SVA

GlobeNewswire

6 months ago

PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024

SVA

GlobeNewswire

6 months ago

VivoPower International PLC Reports Unaudited Preliminary Results for the Six Months Ended December 31, 2023

Smart Sand (NASDAQ:SND) Could Be Struggling To Allocate Capital
SVA

Simply Wall St.

6 months ago

Smart Sand (NASDAQ:SND) Could Be Struggling To Allocate Capital

iBio Announces Participation in 23rd Annual PepTalk Conference
SVA

GlobeNewswire

6 months ago

iBio Announces Participation in 23rd Annual PepTalk Conference

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer
SVA

GlobeNewswire

6 months ago

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

SVA

GlobeNewswire

6 months ago

VIVOPOWER ANNOUNCES FOLLOW-ON STRATEGIC DIRECT INVESTMENT IN TEMBO AT US$120M PRE-MONEY VALUATION

Mirati (MRTX) Gets EU Nod for Krazati in KRAS-Mutated NSCLC
SVA

Zacks

6 months ago

Mirati (MRTX) Gets EU Nod for Krazati in KRAS-Mutated NSCLC

SELLAS (SLS) Rises on FDA Fast Track Tag to Leukemia Candidate
SVA

Zacks

7 months ago

SELLAS (SLS) Rises on FDA Fast Track Tag to Leukemia Candidate

Signing Day Sports Signs Up More Than 1,000 New Student Athletes During Record-Breaking 2023 U.S. Army Bowl Week
SVA

GlobeNewswire

7 months ago

Signing Day Sports Signs Up More Than 1,000 New Student Athletes During Record-Breaking 2023 U.S. Army Bowl Week

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
SVA

ACCESSWIRE

7 months ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network

NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Need
SVA

GlobeNewswire

7 months ago

NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Need

Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil
SVA

GlobeNewswire

7 months ago

Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil

Viracta Therapeutics Provides Clinical Update and Outlook for 2024
SVA

GlobeNewswire

7 months ago

Viracta Therapeutics Provides Clinical Update and Outlook for 2024

Lisata Therapeutics Announces Publication of Case Report on a Complete Response in a Metastatic Gastroesophageal Adenocarcinoma Patient Treated with LSTA1 in Combination with Standard-of-Care Therapy
SVA

GlobeNewswire

7 months ago

Lisata Therapeutics Announces Publication of Case Report on a Complete Response in a Metastatic Gastroesophageal Adenocarcinoma Patient Treated with LSTA1 in Combination with Standard-of-Care Therapy

NanoViricides to Present at the Biotech Showcase in San Fransisco
SVA

ACCESSWIRE

7 months ago

NanoViricides to Present at the Biotech Showcase in San Fransisco

Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023
SVA

GlobeNewswire

7 months ago

Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023

Analysts Expect Breakeven For Dolphin Entertainment, Inc. (NASDAQ:DLPN) Before Long
SVA

Simply Wall St.

7 months ago

Analysts Expect Breakeven For Dolphin Entertainment, Inc. (NASDAQ:DLPN) Before Long

STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech
SVA

GlobeNewswire

7 months ago

STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech

Biodexa Appoints Ann Merchant to the Board of Directors
SVA

GlobeNewswire

7 months ago

Biodexa Appoints Ann Merchant to the Board of Directors

Paragon Technologies Issues Statement to the Stockholders of Ocean Power Technologies. Reminds Stockholders to Vote ONLY the Blue Proxy Card
SVA

ACCESSWIRE

7 months ago

Paragon Technologies Issues Statement to the Stockholders of Ocean Power Technologies. Reminds Stockholders to Vote ONLY the Blue Proxy Card

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for November 2023
SVA

GlobeNewswire

7 months ago

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for November 2023

HNR Acquisition Corp Names Dante Caravaggio Chief Executive Officer, President and Member of the Board of Directors
SVA

ACCESSWIRE

7 months ago

HNR Acquisition Corp Names Dante Caravaggio Chief Executive Officer, President and Member of the Board of Directors

CEO INCREASE IN INDIVIDUAL SHAREHOLDING TO 11.2%
SVA

GlobeNewswire

7 months ago

CEO INCREASE IN INDIVIDUAL SHAREHOLDING TO 11.2%

System1 to Participate in the 2024 ICR Conference
SVA

Business Wire

7 months ago

System1 to Participate in the 2024 ICR Conference

Hywin's debacle underscores close links between China's property and wealth management sectors
SVA

South China Morning Post

7 months ago

Hywin's debacle underscores close links between China's property and wealth management sectors

Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023
SVA

InvestorPlace

7 months ago

Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023

Blackboxstocks, Inc. Signs Definitive Agreement to Acquire Evtec Aluminium, Supplier of Proprietary Parts for the EV, Hybrid, and Performance Automotive Market, with Projected Revenue of US$52 Million for Fiscal Year Ending June 30, 2024
SVA

Business Wire

7 months ago

Blackboxstocks, Inc. Signs Definitive Agreement to Acquire Evtec Aluminium, Supplier of Proprietary Parts for the EV, Hybrid, and Performance Automotive Market, with Projected Revenue of US$52 Million for Fiscal Year Ending June 30, 2024

Lisata Therapeutics Announces Completion of Enrollment in Phase 2b ASCEND Trial of LSTA1 in Metastatic Pancreatic Ductal Adenocarcinoma
SVA

GlobeNewswire

7 months ago

Lisata Therapeutics Announces Completion of Enrollment in Phase 2b ASCEND Trial of LSTA1 in Metastatic Pancreatic Ductal Adenocarcinoma

Viracta Therapeutics Announces Orphan Drug Designation Granted by the U.S. FDA to Nana-val for the Treatment of Nasopharyngeal Carcinoma
SVA

GlobeNewswire

7 months ago

Viracta Therapeutics Announces Orphan Drug Designation Granted by the U.S. FDA to Nana-val for the Treatment of Nasopharyngeal Carcinoma

TechPrecision Corp. Provides Select Unaudited FY2023 Financial Information for Votaw Precision Technologies, Inc.
SVA

ACCESSWIRE

8 months ago

TechPrecision Corp. Provides Select Unaudited FY2023 Financial Information for Votaw Precision Technologies, Inc.

Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
SVA

Zacks

8 months ago

Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data

20 Most Popular Nuts in the World
SVA

Insider Monkey

8 months ago

20 Most Popular Nuts in the World

Viracta Therapeutics Announces Interim Data from Phase 1b/2 Clinical Trial of Nana-val in Patients with Epstein-Barr Virus-Positive Solid Tumors that Show Confirmed Tumor Responses at Higher Dose Levels
SVA

GlobeNewswire

8 months ago

Viracta Therapeutics Announces Interim Data from Phase 1b/2 Clinical Trial of Nana-val in Patients with Epstein-Barr Virus-Positive Solid Tumors that Show Confirmed Tumor Responses at Higher Dose Levels

Polar Power, Inc. Announces Proposed Public Offering of Common Stock
SVA

GlobeNewswire

8 months ago

Polar Power, Inc. Announces Proposed Public Offering of Common Stock

Keystone Dental Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
SVA

GlobeNewswire

8 months ago

Keystone Dental Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

HNR Acquisition Corp Gives a Business Update; Acquired Entity Reports $20.3 million in Revenues and Solid Earnings for the Nine Months Ended September 30, 2023
SVA

ACCESSWIRE

8 months ago

HNR Acquisition Corp Gives a Business Update; Acquired Entity Reports $20.3 million in Revenues and Solid Earnings for the Nine Months Ended September 30, 2023

Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option
SVA

GlobeNewswire

8 months ago

Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

SVA

PR Newswire

8 months ago

iClick Interactive Asia Group Limited Enters into a Definitive Merger Agreement for Going-Private Transaction

Risks Still Elevated At These Prices As Carbon Revolution Public Limited Company (NASDAQ:CREV) Shares Dive 55%
SVA

Simply Wall St.

8 months ago

Risks Still Elevated At These Prices As Carbon Revolution Public Limited Company (NASDAQ:CREV) Shares Dive 55%

SVA

GlobeNewswire

8 months ago

Color Star Technology Received Nasdaq Notification Letter Regarding Bid Price Deficiency

Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period Activity
SVA

GlobeNewswire

8 months ago

Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period Activity

CEA Industries Inc. Reports Third Quarter 2023 Results
SVA

GlobeNewswire

8 months ago

CEA Industries Inc. Reports Third Quarter 2023 Results

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript
SVA

Insider Monkey

8 months ago

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript

Cano Health Provides Update on Third Quarter 2023 10-Q Filing
SVA

PR Newswire

9 months ago

Cano Health Provides Update on Third Quarter 2023 10-Q Filing

Cano Health Announces Financial Results for the Third Quarter 2023
SVA

PR Newswire

9 months ago

Cano Health Announces Financial Results for the Third Quarter 2023

Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
SVA

GlobeNewswire

9 months ago

Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

SVA

Newsfile

9 months ago

Snow Lake Resources Ltd. Announces Participation in Red Cloud's 2023 Fall Mining Showcase in Toronto

CPS Technologies Corporation (NASDAQ:CPSH) Q3 2023 Earnings Call Transcript
SVA

Insider Monkey

9 months ago

CPS Technologies Corporation (NASDAQ:CPSH) Q3 2023 Earnings Call Transcript

SVA

Thomson Reuters StreetEvents

9 months ago

Q3 2023 CURO Group Holdings Corp Earnings Call

Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
SVA

GlobeNewswire

9 months ago

Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Insider Buyers At CURO Group Holdings Recover Some Losses, But Still Down US$56k
SVA

Simply Wall St.

9 months ago

Insider Buyers At CURO Group Holdings Recover Some Losses, But Still Down US$56k

Smith Micro Schedules Teleconference to Announce Third Quarter and Year-to-Date 2023 Financial Results
SVA

Business Wire

9 months ago

Smith Micro Schedules Teleconference to Announce Third Quarter and Year-to-Date 2023 Financial Results

Share on Social Networks: